<DOC>
	<DOCNO>NCT00752219</DOCNO>
	<brief_summary>The purpose study determine whether NXL104 plus ceftazidime effective treatment complicate intra-abdominal infection compare comparator group .</brief_summary>
	<brief_title>Prospective Multicenter Doubleblind Randomized Study NXL104/Ceftazidime + Metronidazole vs. Meropenem Treatment Complicated Intra-abdominal Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Avibactam</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>complicate intraabdominal infection infection limit hollow viscus ischemic bowel disease without perforation acute suppurative cholangitis acute necrotizing pancreatitis pt undergo state abdominal repair , open abdomen technique marsupialization Apache II &gt; 25</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>